When it comes to vaccination, the COVID-19 pandemic divided American society. President Donald Trump and his new Health and ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

The Health and Human Services secretary intends to shift the way vaccines are tested, a move that the agency said will ...

Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.

Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

The unusual move at FDA comes shortly after the agency's longtime vaccine chief was forced out over disagreements with Makary ...

Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking ...

Employee benefits administration firm VeriSource Services is warning that a data breach exposed the personal information of four million people. Identity attacks were rampant in 2024 as attackers ...

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

Moderna MRNA is expected to report first-quarter 2025 earnings on May 1, before the opening bell. The company’s earnings beat ...

Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full ...